PHOENIX - Officials at the Arizona Research Center are searching for two trials of ALT-711 - an investigational drug used to reverse the effects of hypertension.
There are more than 60 testing sites nationally. Patients recruited will receive ALT-711 tablets or placebo one a day for six months.
To qualify, patients must be 50 years old or older, and have a systolic blood pressure of at least 150 mmHg and a diastolic blood pressure of less than 90 mmHg. Both male and female, diabetic and non-diabetic participants are being recruited.
For more information, contact Brook Irving at: 9602) 863-6363.
Long COVID: Urgent Findings, Including Brain Alterations, Call for Renewed Public Health Focus
October 21st 2024New research highlights long COVID’s global impact, cognitive decline, and societal consequences, urging renewed focus on prevention, including vaccination, mask use, and better air quality.
Strengthening Defenses: Integrating Infection Control With Antimicrobial Stewardship
October 11th 2024Use this handout to explain the basics of why infection prevention and control and antimicrobial stewardship are essential and how the 2 fields must have a unified approach to patient and staff safety
NP and PA-Led Practices: A Possible Remedy for Health Care Worker Burnout
October 8th 2024Nurse practitioner (NP) and Physician Assistant (PA)-led practices offer autonomy, flexible schedules, and smaller patient loads, which could help mitigate burnout while reducing pressure on traditional healthcare systems and improving infection prevention.
Barrier Against Infection: Importance and Challenges of Isolation Room Cleaning in Hospitals
October 4th 2024Isolation rooms are essential for infection control in health care, relying on specialized design, advanced cleaning protocols, and technology to prevent cross-contamination and safeguard patient safety.